Top compounds associated with response to LYZL6


Feature Type Standardized
Nominal ANOVA
mRNA Erlotinib CCLE pan-cancer AAC -0.065 0.1
mRNA BRD-K80183349 CTRPv2 pan-cancer AAC -0.046 0.2
mRNA foretinib CTRPv2 pan-cancer AAC -0.05 0.2
mRNA prima-1 CTRPv2 pan-cancer AAC 0.044 0.2
mRNA parbendazole CTRPv2 pan-cancer AAC -0.044 0.2
mRNA NSC95397 CTRPv2 pan-cancer AAC 0.047 0.2
mRNA TKI258 CCLE pan-cancer AAC -0.065 0.2
mRNA WAY-362450 CTRPv2 pan-cancer AAC 0.053 0.2
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.047 0.2
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.045 0.2
Download CSV